-
公开(公告)号:US4421744A
公开(公告)日:1983-12-20
申请号:US379614
申请日:1982-05-18
申请人: James J. Gormley
发明人: James J. Gormley
IPC分类号: G01N33/52 , A61K38/00 , A61P25/00 , A61P25/20 , A61P43/00 , C07K5/02 , C07K5/04 , C07K5/065 , C07K5/087 , C07K5/107 , C07K7/06 , C07K14/70 , A61K37/00 , C07C103/52
CPC分类号: C07K14/70 , C07K5/0207 , C07K5/0212 , C07K5/06078 , C07K5/0812 , C07K5/1016 , A61K38/00 , Y10S514/809
摘要: Peptide and pseudopeptide derivatives of the formula: ##STR1## wherein R.sup.1 and R.sup.2 stand for defined hydrocarbyl or halo-hydrocarbyl substituents, for example alk-2-enyl radicals; .dbd.N--A-- stands for a defined amino acid residue; B, D and E, which may be the same or different, stand for a valency bond or a defined amino acid residue; F stands for a defined amino acid residue; X stands for a carboxy, ester or amide group; and the linkages between the amino acid residues are peptide linkages or at least one of said linkages is a defined pseudo linkage; and pharmaceutically-acceptable salts thereof. Processes for the manufacture of the compounds. Pharmaceutical compositions comprising one of the compounds and a pharmaceutical diluent or carrier. The compounds are antagonists at the opiate receptors, and most of them are selective .delta.-receptor antagonists.
摘要翻译: 下式的肽和假肽衍生物:其中R 1和R 2代表定义的烃基或卤代烃基取代基,例如烷-2-烯基; = N-A-代表定义的氨基酸残基; B,D和E可以相同或不同,代表价键或限定的氨基酸残基; F代表定义的氨基酸残基; X代表羧基,酯或酰胺基; 氨基酸残基之间的连接是肽键,或至少一个所述键是定义的假键; 及其药学上可接受的盐。 用于制造化合物的方法。 包含化合物之一和药物稀释剂或载体的药物组合物。 这些化合物是阿片受体的拮抗剂,其中大多数是选择性的δ-受体拮抗剂。
-
公开(公告)号:US07924549B1
公开(公告)日:2011-04-12
申请号:US12287867
申请日:2008-10-14
IPC分类号: H01G9/00
摘要: Carbon electrodes for a capacitor having conditioned carbon elements in combination with a high concentration of an electrolyte tetrafluoroborate salt and a non-aqueous aprotic solvent to provide an operational voltage up to 4.5V and capacitors used with the carbon electrodes.
摘要翻译: 具有调节碳元素的电容器的碳电极与高浓度的电解质四氟硼酸盐和非水性非质子溶剂的组合,以提供高达4.5V的工作电压和与碳电极一起使用的电容器。
-
公开(公告)号:US4123523A
公开(公告)日:1978-10-31
申请号:US803233
申请日:1977-06-03
申请人: Anand S. Dutta , James J. Gormley , Christopher F. Hayward , John S. Morley , Nigel N. Petter , Gilbert J. Stacey
发明人: Anand S. Dutta , James J. Gormley , Christopher F. Hayward , John S. Morley , Nigel N. Petter , Gilbert J. Stacey
IPC分类号: C07K7/04 , A61K38/00 , A61K38/22 , A61P25/04 , A61P29/00 , C07K1/113 , C07K7/08 , C07K14/575 , C07K14/655 , C07K14/67 , C07K14/675 , A61K37/02 , C07C103/52
CPC分类号: C07K14/6755 , C07K14/672 , A61K38/00
摘要: The disclosure relates to novel polypeptides which possess analgesic and sedative activity, to processes for their manufacture and to compositions containing them. Typical of the peptides disclosed isH-Tyr-D-Ala-Gly-Phe-Leu-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-OH.
摘要翻译: 本公开涉及具有镇痛和镇静活性的新型多肽,其制备方法和含有它们的组合物。 公开的典型的肽是H-Tyr-D-Ala-Gly-Phe-Leu-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-OH。
-
公开(公告)号:US07986510B1
公开(公告)日:2011-07-26
申请号:US12455239
申请日:2009-05-30
IPC分类号: H01G9/00
CPC分类号: H01G11/32 , Y02E60/13 , Y10T29/41 , Y10T29/417
摘要: An electrochemical device having an operational voltage up to 4.5 V in combination with a high concentration of an electrolyte salt consisting of a tetrafluoroborate salt and a eutectic of two solvents in which ethylene carbonate is one and an improved carbon electrode a preferred electrochemical device is a capacitor.
摘要翻译: 具有高达4.5V的操作电压的电化学装置与高浓度的由四氟硼酸盐组成的电解质盐和其中碳酸亚乙酯为一种的两种溶剂和改进的碳电极的优选电化学装置组成的电解质盐是电容器 。
-
公开(公告)号:US4320117A
公开(公告)日:1982-03-16
申请号:US799938
申请日:1977-05-24
申请人: Anand S. Dutta , James J. Gormley , Christopher F. Hayward , John S. Morley , Gilbert J. Stacey
发明人: Anand S. Dutta , James J. Gormley , Christopher F. Hayward , John S. Morley , Gilbert J. Stacey
IPC分类号: C07K14/655 , A61K38/00 , A61P25/04 , C07K1/113 , C07K14/575 , C07K14/67 , C07K14/675 , A61K37/00 , C07C103/52
CPC分类号: C07K14/6755 , A61K38/00 , Y10S514/809
摘要: The disclosure relates to novel polypeptides which possess analgesic activity, to processes for their manufacture and to pharmaceutical compositions containing them. Typical of the peptides disclosed is: ##STR1##
摘要翻译: 本公开涉及具有镇痛活性的新型多肽,其制备方法和含有它们的药物组合物。 公开的典型的肽是:
+ TR -
公开(公告)号:US07713313B1
公开(公告)日:2010-05-11
申请号:US11403326
申请日:2006-04-13
CPC分类号: H01M4/505 , C01G45/1242 , C01G53/54 , C01P2002/50 , C01P2002/54 , H01M10/0525 , H01M2300/004 , Y10T29/49108
摘要: The present invention provides a process for preparing lithium manganate having lithium-in cell stability by utilizing manganese oxides having lower oxidation states in the furnacing step and by using stoichiometric amounts of lithium hydroxide monohydrate and a manganese oxide in water as a starting mixture. Cr, Ni, Mg, AL oxides are optionally added.
摘要翻译: 本发明提供了一种通过在加热步骤中利用具有较低氧化态的锰氧化物和通过使用化学计量的氢氧化锂一水合物和水中的氧化锰作为起始混合物来制备具有锂电池稳定性的锰酸锂的方法。 可选地加入Cr,Ni,Mg,AL氧化物。
-
公开(公告)号:US07829223B1
公开(公告)日:2010-11-09
申请号:US11257293
申请日:2005-10-24
IPC分类号: H01M4/00
CPC分类号: H01M4/525
摘要: There is provided a process for preparing lithium cobaltate and to lithium-containing cobalt oxides which is used in lithium battery cathodes. Also, there is provided cathodes for lithium batteries.
摘要翻译: 提供了一种制备钴酸锂和用于锂电池阴极的含锂钴氧化物的方法。 此外,还提供锂电池的阴极。
-
-
-
-
-
-